Press release
In Vivo Toxicology Market (2026-2033) | Preclinical Testing, Safety Assessment & Drug Development | Top Companies 2026 - Labcorp Drug Development, Taconic Biosciences, Charles River Laboratories
In Vivo Toxicology Market
Get a Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/in-vivo-toxicology-market?kb
United States: Recent Industry Developments
✅ February 2026: Charles River Laboratories expanded in vivo toxicology testing capabilities to support rising demand for preclinical safety studies.
✅ January 2026: Covance (Labcorp) launched integrated toxicology services combining in vivo models with advanced biomarkers for drug safety assessment.
✅ December 2025: Envigo enhanced R&D facilities for regulatory-compliant in vivo studies targeting biologics and gene therapies.
List of Key Players 2026:
MATTEK CORPORATION, Vimta Labs Ltd, Merck KGaA, NUVISAN GmbH, Charles River Laboratories, Eurofins Scientific, Nagi Bioscience, Labcorp Drug Development, PerkinElmer Inc, Taconic Biosciences
Growth Forecast Projected 2026:
The Global In Vivo Toxicology Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Developments 2025-2026:
✅ February 2026: In the United States, laboratories increased deployment of advanced in vivo toxicology models integrating AI-driven data analytics to accelerate drug safety assessments and improve predictive accuracy.
✅ January 2026: Leading CROs expanded capabilities with high-throughput animal testing platforms and real-time monitoring systems to enhance study efficiency and reduce manual intervention.
✅ December 2025: Japan saw accelerated adoption of in vivo toxicology solutions in pharmaceutical and chemical sectors, leveraging predictive modeling and automated monitoring to optimize study outcomes.
✅ November 2025: German organizations reported faster turnaround times and improved study reproducibility by integrating automated dosing, imaging, and data collection systems.
✅ October 2025: China's contract research laboratories upgraded in vivo toxicology facilities with integrated software for workflow management, enhancing compliance with international GLP standards.
How Our Market Research Process Works:
The global In Vivo Toxicology Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the In Vivo Toxicology ecosystem.
Recent Mergers & Acquisitions (M & A):
• Protea Biosciences Group completed acquisition of vivoPharm Pty Ltd., a provider of pharmacology, toxicology and bioanalytical R&D services, expanding preclinical in‐vivo testing capabilities (historical deal integrated relevant toxicology services).
• Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research to enhance early‐phase oncology and functional service provider (FSP) capabilities, expanding CRO services impacting preclinical endpoints (Jan 20, 2026).
• Eli Lilly acquired Orna Therapeutics' in vivo CAR‐T platform assets, integrating novel therapeutic modalities potentially affecting in vivo safety assessment strategies (2026).
• Thermo Fisher Scientific agreed to acquire Clario Holdings (digital clinical data & analytics) in an approx. $8.9 billion deal, enhancing biopharma services which involve clinical and preclinical safety data integration (expected mid‐2026).
• Life sciences M&A activity accelerated in 2025 with US$240 billion in total deal value, setting a backdrop for continued 2026 consolidation that influences CRO/service providers including toxicology specialists.
• Novartis announced $12 billion acquisition of Avidity Biosciences (rare disease biotech), expected to close in 2026, demonstrating Big Pharma strategic acquisitions with implications for safety/development service demand.
• Novo Nordisk's $4.7 billion acquisition of Akero Therapeutics (metabolic disease), expected to close in 2026, representative of large deal environment affecting CRO demand for in vivo toxicology services.
Request Strategic Market Customization: https://datamintelligence.com/customize/in-vivo-toxicology-market?kb
Japan: Recent Industry Developments
✅ February 2026: Japan Tobacco Research Center increased in vivo toxicology studies focused on novel pharmaceuticals and regenerative therapies.
✅ January 2026: Shin Nippon Biomedical Laboratories implemented automated in vivo monitoring systems for high-throughput toxicology testing.
✅ December 2025: Kissei Pharmaceutical partnered with academic institutions to advance predictive toxicology models using in vivo studies.
Major Focused Key Segmentations 2026:
By Product Type: Kits, Reagents, Equipments
By Test Type: Subchronic Toxicity Tests, Chronic Toxicity Tests, Carcinogenicity Tests, Others
By Technology: In vivo Imaging, In Silico Models, Omics Technologies, Others
By End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutions
Regional Growth Analysis for Market:
⇥ North America: Leads the market, driven by high adoption of preclinical testing, pharmaceutical R&D, and advanced laboratory infrastructure.
⇥ Asia-Pacific (including Japan): Dominates global demand, fueled by growing biotechnology research, contract research organizations, and increasing government funding in China, India, and Southeast Asia.
⇥ Europe: Expanding market supported by stringent drug safety regulations, pharmaceutical innovation, and investment in preclinical testing facilities.
⇥ Middle East & Africa: Emerging opportunities from growing pharmaceutical R&D, clinical trials, and bioscience initiatives.
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=in-vivo-toxicology-market?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In Vivo Toxicology Market (2026-2033) | Preclinical Testing, Safety Assessment & Drug Development | Top Companies 2026 - Labcorp Drug Development, Taconic Biosciences, Charles River Laboratories here
News-ID: 4427670 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Automotive Power Electronics Market Expected to Reach USD 9.76 Billion by 2031 a …
Market Growth Driven by Electrification, ADAS Integration, and Smart Vehicle Systems
The global Automotive Power Electronics Market is undergoing a significant transformation as the automotive industry shifts toward electrification, advanced safety technologies, and intelligent vehicle architectures. The market is projected to expand from USD 5.07 billion in 2025 to USD 5.45 billion in 2026, reaching USD 9.56 billion by 2031, growing at a CAGR of 10.8% during 2026-2031.
The increasing adoption of…
Zirconium Market (2026-2033) | Nuclear Applications, Strategic Mining Projects & …
DataM Intelligence has released a new research report titled "Zirconium Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of…
Smart Food Packaging Market to Reach US$54.34 Billion by 2033 at 6.8% CAGR; Nort …
The global Smart Food Packaging Market reached US$32.16 billion in 2024 and is expected to reach US$54.34 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025 to 2033. The market is expanding steadily as the food industry increasingly adopts advanced packaging solutions to enhance food safety, extend shelf life, and improve product quality. Smart food packaging integrates technologies such as sensors, indicators, RFID tags, and…
Drone Battery Swapping Market Expected to Reach US$ 13.9 Billion by 2031 as Oper …
Market Expansion Driven by Need for Continuous Drone Operations and Reduced Downtime
The global Drone Battery Swapping Market reached US$ 12.5 billion in 2022 and is projected to grow to US$ 13.9 billion by 2031, expanding at a CAGR of 4.4% during the forecast period (2024-2031). The market growth is driven by increasing demand for uninterrupted drone operations across commercial, industrial, and defense sectors, where flight time limitations remain a critical…
More Releases for Vivo
Cell and Gene Therapy CRO Market Analysis by Type of Genetic Modification Ex viv …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by…
Vivo City: Redefining Luxury Living in Nelamangala
Nelamangala's [Bangalore] transformation is fuelled by its strategic location and enhanced connectivity. Simultaneously, the relative affordability of land compared to Bengaluru's core districts has spurred significant residential development.
This influx of infrastructure and population has created a dynamic real estate market ripe for innovative projects. SJR Vivo City is positioned to capitalize on this growth, offering a distinct vision of luxury living that caters to the aspirations of modern homebuyers.…
In Vivo Toxicology Market
The global in vivo toxicology market is anticipated to grow at a significant CAGR of over 4% during the forecast period. The increasing investments for R&D are one of the major driving factors for the in vivo toxicology market. The researchers are investing in huge amounts of drugs in the initial levels to reduce the risks of its failure during the later expensive levels of trials. This reduces time consumption…
In Vivo Imaging Systems Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the In Vivo Imaging Systems industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The In Vivo Imaging Systems market survey report has been prepared by conducting market research in a systematic manner. Moreover, the In Vivo Imaging Systems…
In Vivo Imaging Systems Market 2022 | Detailed Report
The In Vivo Imaging Systems research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the…
Ex-Vivo Organ Perfusion Market - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Ex-Vivo Organ Perfusion Market is projected to grow at a CAGR value of around 7.2% during the forecast period [2021 to 2026].
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Ex-Vivo Organ Perfusion Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/ex-vivo-organ-perfusion-market-3460
By Perfusion Technology (Hypothermic Perfusion Technology and Normothermic…
